Archives for News - Page 9
Lessons from the European Experience with Biosimilars
Custom Synthesis, A theme of the AACR panel discussion was the need to educate clinicians and patients about biosimilar products, including what they are and...
Setting a Higher Bar for Interchangeability
Custom Synthesis, Clinicians will also need to be educated about the idea of interchangeability, Dr. Hurvitz continued. An interchangeable product is a biosimilar product that...
Subtle Differences among Biological Products
Custom Synthesis, Despite the requirement to be highly similar, biosimilars and reference products are allowed to have minor differences in clinically inactive ingredients. Furthermore, because...
The Concept of Biosimilarity
Custom Synthesis, Congress paved the way for the approval of biosimilars in 2010 with the passage of the Biologics Price Competition and Innovation Act, which...
Addressing the High Costs of Cancer Drugs
Custom Synthesis, Biological drugs, or biologics, are generally large, complex molecules or mixtures of molecules that are derived from living organisms, such as yeast, bacteria,...
Biological products including biosimilars are large and generally complex molecules
Custom Synthesis, When the patent on the cancer drug trastuzumab (Herceptin) expires next year, patients who have been receiving this biological therapy will have...
Former TiGenix CEO to lead Nordic Nanovector
Custom Synthesis, Nordic Nanovector has appointed Vivet Therapeutic’s chairman and former TiGenix’s CEO, Eduardo Bravo as its new Chief Executive Officer, the company said Monday....
Jardiance reduced risk of kidney disease progression in adults with type 2 diabetes
Custom Synthesis, Boehringer Ingelheim and Eli Lilly have shown consistent effects for Jardiance versus placebo on renal outcomes in patients with established cardiovascular (CV) disease...
What belongs in medical kits for climbers and hikers?
Custom Synthesis, (Reuters Health) – For mountain climbers and hikers, injuries often include broken bones, sprains and skin wounds, but many don’t carry the right...
Global Market Insights says clinical trial management system market worth $2 billion by 2024
Custom Synthesis, Growing prevalence of chronic diseases, surge in clinical trials outsourcing, rising R&D cost and favorable government initiatives will drive global clinical trial management...